Merrithew & Thorsten’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Merrithew & Thorsten's BIIB Position: Q3 2026 in Review
Merrithew & Thorsten sold out of Biogen (BIIB) in Q3 2026, closing a stake of 106 shares — an estimated $22K sold.
Merrithew & Thorsten first reported a position in BIIB in Q4 2025 and held it in 3 quarters. The position peaked at $22K in Q2 2026. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Merrithew & Thorsten reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
- Merrithew & Thorsten sold 106 Biogen shares in Q3 2026, an estimated $22K.
- Merrithew & Thorsten first reported a position in Biogen in Q4 2025 and held it in 3 quarters.
- Merrithew & Thorsten's Biogen position peaked at $22K in Q2 2026.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.